处方药的现状和研究趋势:一个图书统计审查
Changcheng Shi1,2, Xinyi Li1,3, Yan Wu4
1China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
Drug, healthcare and patient safety
|November 24, 2025
概括
抑郁症的研究正在迅速扩大,专注于慢性疾病. 实施科学是有效干预的关键,但需要更广泛的疾病和国家纳入.
科学领域:
- 健康科学 卫生科学 卫生科学
- 图书统计学 图书统计学
- 公共卫生 公共卫生
背景情况:
- 多药制品是一个重大的全球卫生挑战.
- 越来越多地采用降低处方策略来管理多药药的不良影响.
- 了解抑郁症的研究环境对于推进临床实践至关重要.
研究的目的:
- 进行对抑郁症研究进行文献计量分析.
- 识别当前的趋势和在该领域有影响力的研究.
- 绘制全球研究成果和协作模式的地图.
主要方法:
- 从Web of Science核心收藏中系统检索抑郁症研究 (至2024年12月).
- 文献计量分析包括共同作者,引用,共同引用和共同发生的分析.
- 使用VOSviewer,CiteSpace和Bibliometrix软件对研究趋势和网络进行可视化.
主要成果:
- 确定了1809个出版物,显示了过去十年的大幅增长.
- 研究集中在发达国家 (美国,澳大利亚,加拿大),重点关注精神和心脏代谢疾病等慢性疾病.
- 关键主题包括降低障碍,促进者,工具,干预和结果,新兴的重点是药物护理和实施科学.
结论:
- 本文献计量研究提供了对抑郁症研究领域的全面概述.
- 该领域正在发展,但需要更广泛的疾病和地理代表性,特别是来自发展中国家.
- 整合实施科学对于改善描述干预设计和评估至关重要.
相关概念视频
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
CNS Depressants: Barbiturates and Benzodiazepines
1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K
Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
Depressants
370
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
370
Depressive Disorders: Etiology
419
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
419
Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776


